These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 20737543

  • 1. Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders.
    Callaghan RC, Cunningham JK, Sajeev G, Kish SJ.
    Mov Disord; 2010 Oct 30; 25(14):2333-9. PubMed ID: 20737543
    [Abstract] [Full Text] [Related]

  • 2. Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs.
    Callaghan RC, Cunningham JK, Sykes J, Kish SJ.
    Drug Alcohol Depend; 2012 Jan 01; 120(1-3):35-40. PubMed ID: 21794992
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: a population-based assessment.
    Curtin K, Fleckenstein AE, Robison RJ, Crookston MJ, Smith KR, Hanson GR.
    Drug Alcohol Depend; 2015 Jan 01; 146():30-8. PubMed ID: 25479916
    [Abstract] [Full Text] [Related]

  • 5. The incidence of cardiovascular morbidity among patients with bipolar disorder: a population-based longitudinal study in Ontario, Canada.
    Callaghan RC, Khizar A.
    J Affect Disord; 2010 Apr 01; 122(1-2):118-23. PubMed ID: 19647877
    [Abstract] [Full Text] [Related]

  • 6. Parkinson's disease and other neurodegenerative disorders among welders: a Danish cohort study.
    Kenborg L, Lassen CF, Hansen J, Olsen JH.
    Mov Disord; 2012 Sep 01; 27(10):1283-9. PubMed ID: 22833432
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Type 2 diabetes and the risk of Parkinson's disease.
    Hu G, Jousilahti P, Bidel S, Antikainen R, Tuomilehto J.
    Diabetes Care; 2007 Apr 01; 30(4):842-7. PubMed ID: 17251276
    [Abstract] [Full Text] [Related]

  • 9. All-cause mortality among individuals with disorders related to the use of methamphetamine: a comparative cohort study.
    Callaghan RC, Cunningham JK, Verdichevski M, Sykes J, Jaffer SR, Kish SJ.
    Drug Alcohol Depend; 2012 Oct 01; 125(3):290-4. PubMed ID: 22503689
    [Abstract] [Full Text] [Related]

  • 10. Methamphetamine use and schizophrenia: a population-based cohort study in California.
    Callaghan RC, Cunningham JK, Allebeck P, Arenovich T, Sajeev G, Remington G, Boileau I, Kish SJ.
    Am J Psychiatry; 2012 Apr 01; 169(4):389-96. PubMed ID: 22193527
    [Abstract] [Full Text] [Related]

  • 11. Prospective study of coffee consumption and risk of Parkinson's disease.
    Sääksjärvi K, Knekt P, Rissanen H, Laaksonen MA, Reunanen A, Männistö S.
    Eur J Clin Nutr; 2008 Jul 01; 62(7):908-15. PubMed ID: 17522612
    [Abstract] [Full Text] [Related]

  • 12. Dynamics of parkinsonism-Parkinson's disease in residents of adjacent kibbutzim in Israel's Negev.
    Goldsmith JR, Herishanu YO, Podgaietski M, Kordysh E.
    Environ Res; 1997 Jul 01; 73(1-2):156-61. PubMed ID: 9311541
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combined effect of age and severity on the risk of dementia in Parkinson's disease.
    Levy G, Schupf N, Tang MX, Cote LJ, Louis ED, Mejia H, Stern Y, Marder K.
    Ann Neurol; 2002 Jun 01; 51(6):722-9. PubMed ID: 12112078
    [Abstract] [Full Text] [Related]

  • 15. Amphetamine exposure is elevated in Parkinson's disease.
    Garwood ER, Bekele W, McCulloch CE, Christine CW.
    Neurotoxicology; 2006 Dec 01; 27(6):1003-6. PubMed ID: 16620991
    [Abstract] [Full Text] [Related]

  • 16. Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.
    Longo M, Wickes W, Smout M, Harrison S, Cahill S, White JM.
    Addiction; 2010 Jan 01; 105(1):146-54. PubMed ID: 19839966
    [Abstract] [Full Text] [Related]

  • 17. Why is parkinsonism not a feature of human methamphetamine users?
    Moszczynska A, Fitzmaurice P, Ang L, Kalasinsky KS, Schmunk GA, Peretti FJ, Aiken SS, Wickham DJ, Kish SJ.
    Brain; 2004 Feb 01; 127(Pt 2):363-70. PubMed ID: 14645148
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.